Addressing Afib in CABG is critical because ignoring it can result in up to a 24% higher 10-year mortality. ​
​
However, patients often leave the or with their Afib untreated despite a Class I indication.​
​
Contemporary data addresses some of the hesitations of the past, demonstrating that AFib treatment is safe and effective – not only improving survival, but also enhancing quality of life for patients.​
​
Learn more at: <a href="https://okt.to/6lCMBq&quot; target="_blank">https://okt.to/6lCMBq</a&gt;
<a href='https://www.linkedin.com/feed/hashtag/?keywords=STSCoronary2025&highlig…; target='_blank'>#STSCoronary2025</a>​
​
References:​
<a href="https://okt.to/XCqFm5&quot; target="_blank">https://okt.to/XCqFm5</a&gt;​
<a href="https://okt.to/BqUufF&quot; target="_blank">https://okt.to/BqUufF</a&gt;